Russell Hausfeld


Russell Hausfeld is Senior Writer for Psymposia and an investigative journalist and illustrator living in Cincinnati, Ohio. He has a Bachelor's degree in Journalism and Religious Studies from the University of Cincinnati.

ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0”

Through EmpathBio, ATAI Life Sciences says it will develop “safer” MDMA derivatives for patients with PTSD and calls the Multidisciplinary Association for Psychedelic Studies' (MAPS) approach "MDMA 1.0." MAPS' executive director, Rick Doblin, says that if that's the case, ATAI is "MDMA 0.5."

As COMPASS Pathways continues its attempts to build a psychedelic monopoly, Usona Institute keeps publishing open research

Since COMPASS Pathways filed for a controversial psilocybin patent in 2018, Usona Institute has consistently placed its research findings in the public domain.

Forget Plant-Based Medicine, MDMA is Now Made From Crude Oil

MAPS claims the most sustainable way to produce commercial MDMA is through the use of petrochemical feedstocks.

LSD Chemist William Leonard Pickard Has Been Released From Prison

LSD chemist and longtime drug war prisoner, William Leonard Pickard, was officially released from prison on July 27, 2020. Pickard had been locked down since 2000 and was slated to serve two life sentences without the possibility of parole.

MindMed’s CEO Jamon “JR” Rahn Wants Nothing To Do With Those Psychedelic Decrim People

"I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes."

Field Trip Announces “World’s First” Virtual Psychedelic Therapy, But Forgets To Mention They Aren’t the First and No Psychedelics Are Involved

Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.

Psychedelic Video Museum Celebrates Virtual Launch

Contributors to the Daily Psychedelic Video platform gather on Zoom to bless the opening of the Psychedelic Video Museum: a collection of ten years’ worth of their shared visions.

Indie Film ‘Debbie and Doug Drop Acid in the Desert’ is a Visual and Emotional Trip

'Debbie and Doug Drop Acid in the Desert' director, Scott Brown, talks mind-altering drugs, creating psychedelic visual effects, and dealing with depression.

How psychedelic clinical trials are being affected by coronavirus

Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.

Ayahuasca Healings’ Trinity de Guzman calls coronavirus “a necessary purge”

“The Corona Virus is a necessary purge of what is no longer in resonance,” Trinity de Guzman wrote in a recent email to his followers.